Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombocytopenia in carriers and patients with antiphospholipid syndrome: insights from the nationwide START-APS registry.

Internal and emergency medicine·2026
Same author

Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms.

European journal of endocrinology·2026
Same author

Perioperative Treatment of a Patient With Combined Factor IX and XI Deficiency Undergoing Cholecystectomy: A Case Report and Brief Literature Review.

American journal of therapeutics·2026
Same author

Drug Interactions Between Direct Oral Anticoagulants and Nonsteroidal Anti-inflammatory Drugs: A Clinical Risk-Benefit Analysis With Focus on Special Populations.

American journal of therapeutics·2026
Same author

Are the Direct Oral Anticoagulants Better Than Warfarin for the Prevention and Treatment of Stroke and Atrial Fibrillation?

Handbook of experimental pharmacology·2026
Same author

Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression.

The Journal of clinical endocrinology and metabolism·2026

Related Experiment Video

Updated: Jun 4, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Thyroid disorders and hypocoagulability.

Francesco Marongiu1, Doris Barcellona, Antonella Mameli

  • 1Dipartimento di Scienze Mediche Internistiche Mario Aresu, University of Cagliari, Cagliari, Italy. marongiu@medicina.unica.it

Seminars in Thrombosis and Hemostasis
|February 11, 2011
PubMed
Summary

Thyroid disorders can cause bleeding problems (hypocoagulability) by affecting blood clotting and clot breakdown. Recognizing and managing these hemostatic issues is crucial for patient care in both hyperthyroidism and hypothyroidism.

Related Experiment Videos

Last Updated: Jun 4, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

  • Endocrinology
  • Hematology
  • Internal Medicine

Background:

  • The link between thyroid dysfunction and hemostatic abnormalities is often overlooked in clinical practice.
  • Impaired hemostasis and fibrinolysis can occur in patients with thyroid disorders.
  • This interaction requires greater recognition by healthcare professionals.

Purpose of the Study:

  • To highlight practical aspects of the relationship between thyroid disorders and hypocoagulability.
  • To emphasize the clinical significance of hemostatic impairments in thyroid disease management.
  • To improve physician and endocrinologist awareness of bleeding risks.

Main Methods:

  • Review of existing literature on thyroid disorders and hemostasis.
  • Analysis of clinical implications of hypocoagulability in hyper- and hypothyroidism.
  • Discussion of potential pathogenetic mechanisms.

Main Results:

  • Thyroid disorders can lead to mild bleeding tendencies, often reversible with euthyroid state restoration.
  • Severe hemorrhagic events can occur, associated with conditions like thrombocytopenia, acquired von Willebrand syndrome, and acquired hemophilia.
  • Pathogenesis involves direct thyroid hormone effects or autoimmune mechanisms.

Conclusions:

  • Physicians must be vigilant for hemorrhagic events and laboratory coagulation abnormalities in patients with thyroid disorders.
  • Understanding the interplay between thyroid status and hemostasis is vital for preventing severe bleeding.
  • Prompt diagnosis and management of these hemostatic issues are essential.